Delhi High Court Upholds Injunction Against ‘Medilice Lice Killer’ Trademark

The Delhi High Court upheld a permanent injunction restraining Rapple Healthcare from using the mark “Medilice Lice Killer”, holding that it infringed and amounted to passing off of “MEDILICE”, a registered trademark of Wings Pharmaceuticals.

The Court found that although Wings sold MEDILICE as a shampoo and Rapple marketed a hair oil, both products addressed the same consumer need of lice treatment, creating a likelihood of confusion among consumers.

However, the Court reduced the damages awarded from ₹10 lakh to ₹3 lakh, observing that punitive damages must be specifically pleaded and justified.

[Shri Kirit Bhadiadra v. Wings Pharmaceuticals Pvt Ltd.]